$15.09 $0.25 per serving
Product analysis
Herbal Extract Memory Complex brings a small group of ingredients together for people seeking a memory-oriented blend. Missing preparation details and ginkgo mixture proportions make the combination harder to compare.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality30
Ginkgo markers are named, but the quality of the complete combination remains uncertain. Vinpocetine and Chinese club moss lack specific preparation details.
Ingredient Transparency60
All listed ingredient amounts are disclosed. Most specific forms and the proportions within the ginkgo mixture are omitted.
Value For Money55
Vinpocetine offers favorable value for its amount at the full serving price. Value for ginkgo and Chinese club moss remains uncertain, leaving the complete combination harder to judge.
Customer Satisfaction79
Customer ratings are favorable. The substantial number of ratings provides a broad picture of satisfaction.
Product Focus61
The short combination has a memory-oriented purpose. Its connection to a particular outcome remains limited, so the focused ingredient list should not be taken as a promise of improvement.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.25
- Customer rating
- 4.6 · 914 ratings
Goals
Impact
Moderate effect
Impact
Moderate effect
Vinpocetine · 15 mg
Vinpocetine Not classified
No linked studies yet.
Impact
High effect
Impact
High effect
Impact
Moderate effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Ginkgo biloba leaf extract (Flavone Glycosides, Terpene Lactones) | 120 mg | |
Vinpocetine | 15 mg | |
Huperzia serrata extract | 7.5 mg |
Vinpocetine · 15 mg OverallScore92
The serving states 15 mg of vinpocetine, with a moderate cost per 10 mg. The other ingredients include a gelatin capsule.
How this ingredient is rated
Active Ingredient Quality & Bioavailability91
Vinpocetine is named and its amount is stated. The other ingredients include a gelatin capsule.
Vinpocetine Identity and Source
Vinpocetine is named with a specific amount.
Excipient and Filler Quality
The other ingredients include a gelatin capsule.
Dose, Safety & Label Transparency100
The serving provides 15 mg of vinpocetine and states its individual amount.
Vinpocetine Dosage Alignment
The serving provides 15 mg of vinpocetine.
Proprietary Blend Disclosure
The individual vinpocetine amount is stated.
Value80
The cost per 10 mg of vinpocetine is moderate.
Cost Efficiency per 10mg Dose
The cost per 10 mg of vinpocetine is moderate.
Ginkgo (Flavone Glycosides, Terpene Lactones) · 120 mg OverallScore85
Each serving provides 120 mg of ginkgo leaf extract, with the amount and source disclosed. The extract specifies 24% flavones and 6% terpenes. No qualifying ginkgolic acid limit is documented. The available information does not assess value.
How this ingredient is rated
Composition and Label Disclosure70
The extract specifies 24% flavones and 6% terpenes. No qualifying ginkgolic acid limit is documented.
Marker and Preparation Disclosure
The extract specifies 24% flavones and 6% terpenes.
Declared Ginkgolic Acid Limit
No qualifying ginkgolic acid limit is documented.
Composition and Label Disclosure100
The serving lists 120 mg of ginkgo leaf extract.
Individual Preparation Amount Disclosure
The amount and source are disclosed: 120 mg of ginkgo leaf extract per serving.
Commercial Price and Usability
Value was not assessed.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
- Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
- Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
- Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
- Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
- Combination of Vinpocetine and Dexamethasone Alleviates Cognitive Impairment in Nasopharyngeal Carcinoma Patients following Radiation Injury.
- Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
- Role of sodium channel inhibition in neuroprotection: effect of vinpocetine.
- Effect of vinpocetine (cognitol™) on cognitive performances of a nigerian population.
- [Study of the effects of vinpocetin on cognitive functions].
- Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
- A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
- Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
- Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
- Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
- Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
- [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
- Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
- [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
- [Effect of vasoactive agents on visual functions and ocular blood flow in patients with early manifestations of age-related macular degeneration].